about
AION Labs is a venture studio built to connect pharma R&D with the next wave of AI, technology, and scientific innovation. It is a unique partnership formed by AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and AWS.
AION Labs combines deep pharmaceutical R&D expertise with cutting-edge technology to create de-risked, industry-aligned ventures. Through its co-development model, startups gain early access to pharma insights, R&D champions, and real-world validation opportunities, alongside structured company-building support and funding.
Company
Creation Tracks
AION Labs’ company creation process, through both the AION Building and AION Seeding tracks, addresses unmet
industry needs through a rigorous validation process. Both tracks provide funding and support, differing in
development stages and technology maturity.
industry needs through a rigorous validation process. Both tracks provide funding and support, differing in
development stages and technology maturity.
AION Building
The AION Building track is designed for scientists and tech founders looking to tackle predefined challenges set by AION Labs in collaboration with its pharma partners. Participants work on solving specific, high-impact problems through a structured, collaborative workshop.
Read more
AION Seeding
The AION Seeding track is tailored for scientists and tech founders of existing early-stage startups or with technologies transitioning from academia. Participants bring their own solutions, which are validated through AION Labs Pharma partners, funded and supported
Read more